A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer

JOURNAL ARTICLE published December 2018 in Basic and Clinical Andrology

Authors: Jumpei Asakawa | Taro Iguchi | Satoshi Tamada | Sayaka Yasuda | Noriko Ninomiya | Minoru Kato | Takeshi Yamasaki | Tetusji Ohmachi | Tatsuya Nakatani